Latest Biotech News

The FDA approved lenacapavir (Yeztugo) for HIV prevention, marking a milestone after decades of development. This long-acting injectable offers biannual dosing, improving adherence and prevention...

A comprehensive proteomic study has revealed that lethal melanomas overexpress mitochondrial protein synthesis and metabolic pathways that sustain tumor growth. Targeting these pathways with...

Analysis of over 300,000 Swedish births indicates that maternal age above 40 significantly increases risks of stillbirth, prematurity, low birth weight, and neonatal hypoglycemia. Using data from...

Researchers developed an innovative three-layer composite material that enhances solar water splitting efficiency by eightfold, boosting sustainable green hydrogen generation. Combining cobalt...

A study reveals that the Nrf2-HMOX1 axis plays a central role in non-small cell lung cancer’s resistance to cisplatin by suppressing ferroptosis, a regulated form of cell death linked to...

Scientists at the Spanish National Cancer Research Centre (CNIO), in collaboration with the University of Cambridge and biotech startup Tailor Bio, have developed a genomic test that predicts...

Researchers at the University of Pennsylvania have isolated novel anticancer peptides from the toxic fungus Aspergillus flavus, transforming a historically harmful microbe into a promising drug...

GLP-1 receptor modulators, initially developed for diabetes treatment in the 1970s, have emerged as leading drugs for substantial non-surgical weight loss, achieving 15-20% reductions in body...

The FDA granted approval for Gilead’s lenacapavir (Yeztugo), a novel HIV prevention drug administered twice yearly, marking a significant advance in prophylactic treatment strategies. This...

A proteomic study analyzing 151 tumor and normal samples has uncovered that aggressive melanomas exhibit hyperactivation of mitochondrial protein synthesis and metabolic pathways fueling tumor...

Researchers at Linköping University crafted a novel three-layer composite material integrating Ni(OH)2, Co3O4, and cubic silicon carbide (3C-SiC) that enhances photocatalytic water splitting...

A collaborative study between University of Gothenburg and Leipzig researchers revealed that recycled polyethylene pellets release over 80 different chemicals into water, some acting as endocrine...

An extensive study of over 300,000 Swedish births from 2010 to 2022 assessed neonatal outcomes relative to maternal age beyond 35. Findings show that mothers aged 45+ face notably increased risks...

Researchers announced development of translational read-through-inducing drugs (TRIDs) capable of bypassing premature stop codons caused by nonsense mutations in Fanconi anemia genes. These small...

Recent administrative leave placements of Nicole Verdun, MD, and deputy Rachael Anatol, PhD, from the FDA’s Office of Therapeutic Products (OTP) have reignited concerns over cell and gene therapy...

Caris Life Sciences recently completed a $494 million IPO, marking a significant financial milestone amid a general freeze on biopharma initial public offerings. The company applies artificial...

The FDA's Office of Therapeutic Products witnessed abrupt senior staff changes, including the administrative leave of Nicole Verdun, MD, and deputy Rachael Anatol, PhD. Verdun was instrumental in...

New research has highlighted the Nrf2-HMOX1 signaling pathway as a key mediator of cisplatin resistance in non-small cell lung cancer (NSCLC). By suppressing ferroptosis, a form of regulated cell...

Researchers have developed translational read-through-inducing drugs (TRIDs) designed to counteract nonsense mutations in Fanconi anemia patients. These drugs facilitate ribosomal bypass of...

A pioneering artificial intelligence system employing convolutional neural networks and Mel-spectrogram analysis can accurately assess severity in unilateral vocal cord paralysis. This...